ECS vs NEU

ASX Healthcare sector comparison — updated 14 Jul 2026 — Healthcare sector

ECS

ECSBOTANIC FPO [ECS]

50MEDIUM

NEU

NEUREN FPO NZ [NEU]

47LOW

Score Breakdown

ECS NEU
Technical
33
61
Catalyst
53
50
Sentiment
50
50
Fundamental
61
62
Momentum
53
26
Risk Gate
27
43

Key Metrics

ECS Metric NEU
$8.0MMarket Cap$2.1B
1.4MAvg Volume (20d)725K
N/AShort Interest+4.9%
$0.01052-Week High$22.985
$0.00352-Week Low$11.000
-20.0%Daily Change+0.2%
$0.004Reference Price$16.530
N/AROE+8.7%
N/AProfit Margin+47.1%

Active Signals

ECS Signals

RSI drifting toward oversold territory — worth watching
Stochastic turning bearish from a high level — caution
Trading below both moving averages — the trend is working against this one
Took a hit — down 20.0% over the last 5 days
Volume-price trend says buyers are quietly accumulating — price hasn't caught up yet
Below the 200-day average — the long-term trend is still working against it
Strong cash runway (16 quarters)
Very high P/S ratio (2211.4x)

NEU Signals

Beating the Small Ords index — relative strength of 1.37, so it's outpacing the pack
Trading above the 200-day average — the long-term trend is on your side
Cash positive / operating cashflow positive
Revenue in sharp decline (-81%)
Piotroski F-Score strong (7/9, low-confidence approx)
EPS estimates revised upward (+10pts)
Post-earnings drift: negative surprise (SUE -10)
Earnings in sharp decline (-88% QoQ)

Ask Scout AI to compare ECS and NEU in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

ECS vs PHX →ECS vs RAC →ECS vs TRI →ECS vs TRU →EIQ vs EZZ →
ECS Full Analysis → NEU Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).